U.S. federal trademark · Serial No. 97436362
research and development services for the development of monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases; clinical trials for others involving monoclonal antibodies used in connection with complement therapies to treat autoimmune diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.